Shandong Buchang Pharmaceuticals (603858.SH) has spent 528 million yuan to repurchase 3.03% of its shares.
BuXiang Pharmaceuticals (603858.SH) announced that as of September 18, 2024, the company has completed the central competitive bidding...
Shandong Buchang Pharmaceuticals (603858.SH) announced that as of September 18, 2024, the company has repurchased a total of 33.5555 million shares through centralized bidding trading. The repurchased shares account for 3.03% of the company's total share capital. The highest purchase price was 17.44 yuan per share and the lowest purchase price was 14.16 yuan per share. The total amount paid for the repurchases so far is 528 million yuan (excluding transaction fees).
Related Articles
US Stock Market Move | Planning to Raise $60 Billion to Pave the Way for Computing Power for AI Companies Broadcom Inc.(AVGO.US) Rose About 2.9%
Muse user growth momentum is strong, but long-term monetization prospects remain uncertain; BNP Paribas maintains an "Outperform" rating on Meta (META.US).
US Stock Market Move | Market expectations for a Fed rate hike in October cool down, cryptocurrency-related stocks rise.
US Stock Market Move | Planning to Raise $60 Billion to Pave the Way for Computing Power for AI Companies Broadcom Inc.(AVGO.US) Rose About 2.9%
Muse user growth momentum is strong, but long-term monetization prospects remain uncertain; BNP Paribas maintains an "Outperform" rating on Meta (META.US).
US Stock Market Move | Market expectations for a Fed rate hike in October cool down, cryptocurrency-related stocks rise.
